LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 227

Search options

  1. Article ; Online: How does a clinician approach the pharmacological management of opioid use disorders in pregnant women and pregnant people?

    Jones, Hendrée E

    Expert opinion on pharmacotherapy

    2023  Volume 24, Issue 4, Page(s) 401–405

    MeSH term(s) Pregnancy ; Female ; Humans ; Pregnant Women ; Opioid-Related Disorders/drug therapy ; Methadone/therapeutic use ; Buprenorphine/therapeutic use ; Opiate Substitution Treatment ; Pregnancy Complications/drug therapy ; Analgesics, Opioid/adverse effects
    Chemical Substances Methadone (UC6VBE7V1Z) ; Buprenorphine (40D3SCR4GZ) ; Analgesics, Opioid
    Language English
    Publishing date 2023-01-12
    Publishing country England
    Document type Editorial
    ZDB-ID 2001535-5
    ISSN 1744-7666 ; 1465-6566
    ISSN (online) 1744-7666
    ISSN 1465-6566
    DOI 10.1080/14656566.2023.2165909
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book: Treating women with substance use disorders during pregnancy

    Jones, Hendrée E. / Kaltenbach, Karol

    a comprehensive approach to caring for mother and child

    2013  

    Author's details Hendrée E. Jones and Karol Kaltenbach
    Keywords Substance-Related Disorders / therapy ; Pregnancy Complications
    Language English
    Publisher Oxford Univ. Press
    Publishing place Oxford u.a.
    Publishing country Great Britain
    Document type Book
    Note Includes bibliographical references and index
    HBZ-ID HT017622133
    ISBN 978-0-19-996855-8 ; 9780199969562 ; 0-19-996855-1 ; 0199969566
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Article ; Online: Implementation of a Standardized Clinical Definition of Opioid Withdrawal in the Neonate: Challenges and Opportunities.

    Jilani, Shahla M / Jones, Hendrée E / Davis, Jonathan M

    JAMA

    2022  Volume 327, Issue 17, Page(s) 1643–1644

    MeSH term(s) Analgesics, Opioid/adverse effects ; Humans ; Infant, Newborn ; Narcotics ; Neonatal Abstinence Syndrome/diagnosis ; Opioid-Related Disorders/diagnosis ; Opioid-Related Disorders/drug therapy ; Substance Withdrawal Syndrome/diagnosis
    Chemical Substances Analgesics, Opioid ; Narcotics
    Language English
    Publishing date 2022-04-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2958-0
    ISSN 1538-3598 ; 0254-9077 ; 0002-9955 ; 0098-7484
    ISSN (online) 1538-3598
    ISSN 0254-9077 ; 0002-9955 ; 0098-7484
    DOI 10.1001/jama.2022.5406
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions.

    DeLisle, Alexa / Jones, Hendrée E / Jansson, Lauren M

    Journal of addiction medicine

    2022  Volume 17, Issue 2, Page(s) 123–125

    Abstract: Gabapentin is a γ-aminobutyric acid analog formally indicated for the treatment of epilepsy and neuropathic pain that is gaining increased popularity. Gabapentin has been historically considered a safe medication, including during pregnancy and lactation, ...

    Abstract Gabapentin is a γ-aminobutyric acid analog formally indicated for the treatment of epilepsy and neuropathic pain that is gaining increased popularity. Gabapentin has been historically considered a safe medication, including during pregnancy and lactation, with low reported concerns for misuse and use disorders. However, new empirical efforts are revealing concerns regarding the safety of widespread gabapentin use, particularly in pregnancy and for individuals with a propensity toward substance misuse. The Food and Drug Administration's full prescribing information report on gabapentin provides concerning preclinical data and then states that gabapentin is potentially "developmentally toxic" and has an unknown risk of birth impacts. Concerns have also been raised surrounding in utero exposure to gabapentin due to the onset and presentation of atypical and/or difficult to control withdrawal signs and symptoms in neonates, including those dually exposed to opioids, as well as neonatal exposure to gabapentin via breastmilk. Moreover, nonprescribed gabapentin use has become an increasing problem, with opioid use disorder being the greatest risk factor for such misuse. This article summarizes the current literature regarding gabapentin use during pregnancy and related prenatal and neonatal exposure outcomes with special consideration for interactions between gabapentin and opioid use. Taken together, the current literature suggests that gabapentin use should be considered with caution during pregnancy and during the post-partum period. Well-controlled, prospective research studies are needed to determine the extent of the risks and benefits of prescribed and nonprescribed gabapentin exposure to pregnant people and their neonates.
    MeSH term(s) Female ; Pregnancy ; Infant, Newborn ; Humans ; Gabapentin/adverse effects ; Analgesics, Opioid/adverse effects ; Prospective Studies ; gamma-Aminobutyric Acid/adverse effects ; Cyclohexanecarboxylic Acids/adverse effects ; Amines/adverse effects ; Opioid-Related Disorders/drug therapy ; Lactation
    Chemical Substances Gabapentin (6CW7F3G59X) ; Analgesics, Opioid ; gamma-Aminobutyric Acid (56-12-2) ; Cyclohexanecarboxylic Acids ; Amines
    Language English
    Publishing date 2022-09-06
    Publishing country United States
    Document type Journal Article
    ISSN 1935-3227
    ISSN (online) 1935-3227
    DOI 10.1097/ADM.0000000000001065
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Drug Use Among Women and Children in Afghanistan: The Complexities of An Important Public Health Issue.

    Momand, Abdul Subor / Jones, Hendrée E

    HSOA journal of addiction & addictive disorders

    2020  Volume 7, Issue 1

    Abstract: National surveys of drug use among those living in Afghanistan shows multiple substances are easily accessible and commonly used in combination. The drug use situation in Afghanistan is complex and compounded with concern for its future given that ... ...

    Abstract National surveys of drug use among those living in Afghanistan shows multiple substances are easily accessible and commonly used in combination. The drug use situation in Afghanistan is complex and compounded with concern for its future given that Afghanistan is a country comprised of individuals who almost half (48%) are under the age of 15. The number of women and children reported drug use have been increased alarmingly in last one and half decades. However, drug treatment services expanded in urban areas of Afghanistan but still there is need for evidence based and culturally appropriate drug prevention and treatment program in rural areas and to fulfill the constitutional obligation there is an obvious need for strong institutions to refine coordination of counternarcotic efforts.
    Language English
    Publishing date 2020-01-31
    Publishing country United States
    Document type Journal Article
    ISSN 2578-7276
    ISSN (online) 2578-7276
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Case Series of Individuals Treated with Naltrexone during Pregnancy for Opioid and/or Alcohol Use Disorder.

    Wachman, Elisha M / Saia, Kelley / Bressler, Jonathan / Werler, Martha / Carter, Ginny / Jones, Hendree E

    Journal of addiction medicine

    2024  

    Abstract: Objective: There is a lack of knowledge about the relative safety and efficacy of naltrexone for the treatment of pregnant individuals with opioid and/or alcohol use disorder, including the range of outcomes, in both the pregnant individual and the ... ...

    Abstract Objective: There is a lack of knowledge about the relative safety and efficacy of naltrexone for the treatment of pregnant individuals with opioid and/or alcohol use disorder, including the range of outcomes, in both the pregnant individual and the infant, over the course of peripartum period. Our objective was to describe these outcomes in a cohort of pregnant individuals on naltrexone.
    Methods: In this prospective case series, 7 pregnant individuals with opioid use disorder (OUD) or alcohol use disorder (AUD) treated with naltrexone were followed from pregnancy through 12 months after delivery. Clinical treatment protocols and outcomes related to safety and efficacy during pregnancy, delivery, and the postpartum period are described.
    Results: There were 4 pregnant individuals with OUD and 3 with AUD, of which 3 were managed with oral and 4 with extended-release naltrexone. The mean gestational age at study enrollment was 21.7 (SD, 12) weeks. Of the 7 participants, there was no return to nonprescribed opioid use and 2 who experienced a return to alcohol use over the course of the study. All individuals delivered vaginally at a mean of 37 weeks gestation without any peripartum pain difficulties. Five of the individuals (71.4%) remained on naltrexone 12 months after delivery. There were no reported fetal anomalies and one preterm delivery. None of the infants developed neonatal opioid withdrawal syndrome.
    Conclusions: For pregnant individuals with OUD or AUD treated with naltrexone, there were low rates of return to nonprescribed use and reassuring pregnant person and infant outcomes to 12 months postpartum.
    Language English
    Publishing date 2024-02-14
    Publishing country Netherlands
    Document type Journal Article
    ISSN 1935-3227
    ISSN (online) 1935-3227
    DOI 10.1097/ADM.0000000000001293
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Comprehensive Treatment for Pregnant and Parenting Women with Substance Use Disorders and Their Children: The UNC Horizons Story.

    Jones, Hendrée E / Andringa, Kim / Carroll, Senga / Johnson, Elisabeth / Horton, Evette / O'Grady, Kevin / Stanford, Deborah / Renz, Connie / Thorp, John

    Maternal and child health journal

    2024  Volume 28, Issue 3, Page(s) 409–425

    Abstract: Objectives: To describe how the UNC Horizons program, a comprehensive women-centered program for pregnant and parenting women with substance use disorders, and its patient population have changed over time and summarize basic neonatal outcomes for ... ...

    Abstract Objectives: To describe how the UNC Horizons program, a comprehensive women-centered program for pregnant and parenting women with substance use disorders, and its patient population have changed over time and summarize basic neonatal outcomes for infants born to women in treatment at Horizons.
    Methods: Yearly Annual Reports from fiscal years of 1994 to 2017 were abstracted. Patient characteristics and infant outcomes compared to normative North Carolina data were examined.
    Results: Highlights of findings include: The percentage of women for whom opioids were the primary substance of use increased from 0% in 1995-1996 to 62% in 2016-17, while cocaine decreased from 66 to 12%. Intravenous substance use history increased from 7% in 1994-1995 to 41% in 2016-2017. The number of women reporting a history of incarceration rose from 10-20% in the early years to 40%-50% beginning in 2007-2008. The proportion of women reporting a desire to hurt themselves rose from 20% in 2004-2005 to 40% in 2016-2017. Self-reported suicide attempt history remained consistent at 32% across years. While reporting of childhood physical abuse remained at 38% across years, reporting of sexual abuse and domestic violence trended upward. Horizons did not differ from North Carolina in the likelihood of patients giving birth prematurely [χ
    Conclusions for practice: Breaking the cycle of addiction for women and children must focus on helping women with substance use problems develop a sense of hope that their lives can improve, and a sense of feeling safe and nurtured.
    MeSH term(s) Infant, Newborn ; Infant ; Child ; Pregnancy ; Humans ; Female ; Parenting ; Substance-Related Disorders/epidemiology ; Infant, Low Birth Weight ; Domestic Violence ; Analgesics, Opioid
    Chemical Substances Analgesics, Opioid
    Language English
    Publishing date 2024-01-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1339905-6
    ISSN 1573-6628 ; 1092-7875
    ISSN (online) 1573-6628
    ISSN 1092-7875
    DOI 10.1007/s10995-023-03870-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The Stimulant Crisis Intertwined With the Opioid Crisis: A Compassionate Response for Dyadic Health and Well-Being.

    Jones, Hendrée E / Nakagawa, Jenna / Johnson, Elisabeth

    American journal of public health

    2021  Volume 111, Issue 8, Page(s) 1436–1438

    MeSH term(s) Amphetamine-Related Disorders/therapy ; Delivery of Health Care ; Empathy ; Humans ; Opioid Epidemic ; Opioid-Related Disorders/therapy ; Public Health
    Language English
    Publishing date 2021-08-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 121100-6
    ISSN 1541-0048 ; 0090-0036 ; 0002-9572
    ISSN (online) 1541-0048
    ISSN 0090-0036 ; 0002-9572
    DOI 10.2105/AJPH.2021.306373
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Cultural Adaptation and Validation of the Urdu Version of the Cognitive Emotion Regulation Questionnaire (CERQ) in Male Patients With Substance Use Disorders (SUDs) in Pakistan.

    Shahzad, Salman / Bano, Nasreen / Begum, Nasreen / Jones, Hendrée E

    Frontiers in psychiatry

    2022  Volume 13, Page(s) 812075

    Abstract: Background: Adults with substance use disorders (SUDs) often have co-occurring mental health problems. Emotion regulation may play a vital role in mental health problems. The Cognitive Emotion Regulation Questionnaire (CERQ) is a widely used measure for ...

    Abstract Background: Adults with substance use disorders (SUDs) often have co-occurring mental health problems. Emotion regulation may play a vital role in mental health problems. The Cognitive Emotion Regulation Questionnaire (CERQ) is a widely used measure for assessing cognitive emotion regulation. However, it has not been used in Pakistan on patients with co-occurring SUDs and mental health issues. The present study aims to translate and adapt the CERQ into the Urdu language and to determine its reliability and convergent validity in a sample of male patients with SUDs in Pakistan.
    Method: Participants completed a demographic information form, the CERQ, the Depression, Anxiety, and Stress Scale Short Form [DASS-21)], and the Rosenberg Self-Esteem Scale [RSES)] in Urdu.
    Results: Male participants (
    Conclusion: The Urdu version of the CERQ is a reliable measure for investigating cognitive emotion regulation strategies related to mental health and SUDs in Pakistan.
    Language English
    Publishing date 2022-05-31
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564218-2
    ISSN 1664-0640
    ISSN 1664-0640
    DOI 10.3389/fpsyt.2022.812075
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A Dyadic Framework of Care for Opioid-exposed Birthing Persons and Their Infants and Children.

    Jilani, Shahla M / Davis, Jonathan M / Grossman, Matthew / Jones, Hendrée E / Terplan, Mishka / Jansson, Lauren M

    The Journal of pediatrics

    2023  Volume 266, Page(s) 113893

    Abstract: Objective: To develop a dyadic-centered framework focused on clinical care, surveillance, and research for birthing persons with opioid use disorder (OUD) and their infants and children.: Study design: Between February and March 2023, an analysis was ...

    Abstract Objective: To develop a dyadic-centered framework focused on clinical care, surveillance, and research for birthing persons with opioid use disorder (OUD) and their infants and children.
    Study design: Between February and March 2023, an analysis was conducted within the US Department of Health and Human Services (HHS) of activities directed at opioid-exposed birthing persons and their infants and children (the dyad) to identify: 1) number of activities, stratified by type and 2) characteristics across health and supportive activities that serve the dyad vs birthing persons or infants and children individually. Descriptive and thematic analyses were used to assess quantity and characteristics of fiscal year 2023-2024 activities aggregated across eleven HHS agencies.
    Results: Of 181 activities examined, 75 met inclusion criteria specific to serving birthing persons with OUD and opioid-exposed infants and children. Sixty-two percent of activities were dyad focused. Five categories of dyadic activities were identified: research (45%), education and training (28%), health and supportive services (21%), surveillance (4%), and quality improvement (2%). Eight specific characteristics were key to dyadic activities: a life course and generational approach, emphasis on relationship, dyadic outcomes, service wraparound, payment structures supporting dyadic care, data linkage, and social determinants of health.
    Conclusions: This analysis of HHS activities directed at birthing persons with OUD and opioid-exposed infants and children showed that most programs had a dyadic focus. Synthesizing elements identified from activities serving the dyad facilitated the development of a dyadic framework integrating clinical care, public health surveillance, and research.
    MeSH term(s) Infant ; Child ; Humans ; Analgesics, Opioid/therapeutic use ; Opioid-Related Disorders/epidemiology
    Chemical Substances Analgesics, Opioid
    Language English
    Publishing date 2023-12-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3102-1
    ISSN 1097-6833 ; 0022-3476
    ISSN (online) 1097-6833
    ISSN 0022-3476
    DOI 10.1016/j.jpeds.2023.113893
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top